Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca
PharmaVOICE sat down with Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca, who disclosed her personal career journey with oncology and drug development as she works to improve patients’ lives.
Bhavin Patel, Associate Principal, Market Access Center of Excellence, IQVIA
Say Niyogi, Principal, Market Centers of Excellence, IQVIA
Ross Perak, Sr Principal, Market Access Center of Excellence, IQVIA
Kim Boericke, ICON Commercialization and Outcomes Services
Andrew Burkus, Principal, Omnichannel Consulting Group
Kit Grimshaw, Offering Lead Measurement Optimization and Platform, IQVIA
Daniel Vun Kannon, Associate Product Director, IQVIA
Scott Thompson, Co-CEO, Acceleration Point
Bill McEllen, Partner, Fingerpaint
Brannon Cashion, Managing Partner, Leaderboard Branding, Fingerpaint
Taren Grom, Editor, PharmaVOICE (Moderator)
Amy Kissam-Sands, Senior Vice President, Clinical Operations, Parexel
Tim Audin, Senior Director, Risk Management (IRMCert) Parexel
Taren Grom, Editor, PharmaVOICE (Moderator)
Amy Kissam-Sands, Senior Vice President, Clinical Operations, Parexel
Tim Audin, Senior Director, Risk Management (IRMCert) Parexel
Taren Grom, Editor, PharmaVOICE (Moderator)
Amy Kissam-Sands, Senior Vice President, Clinical Operations, Parexel
Tim Audin, Senior Director, Risk Management (IRMCert) Parexel
